Contact number
+1 202 551 1700Provided by Chambers
Provided by Chambers
The firm has relevant industry experience, is competent and reliable. It provides robust support when handling complex matters.
The team really understands the industry and has a substantial knowledge on regulatory compliance.
Paul Hastings is excellent; the team's work product is so technically understandable for normal human beings and they provide really good client service.
The firm has relevant industry experience, is competent and reliable. It provides robust support when handling complex matters.
The team really understands the industry and has a substantial knowledge on regulatory compliance.
Paul Hastings is excellent; the team's work product is so technically understandable for normal human beings and they provide really good client service.
Provided by Chambers
Philip Katz of Hogan Lovells US LLP is well noted for his expertise in an array of FDA matters. He has strength in issues relating to orphan drugs designation and regulatory exclusivity.
Lynn Mehler of Hogan Lovells US LLP handles a range of FDA regulatory matters for pharmaceutical clients, from approvals to risk evaluation strategies.
Lynn's knowledge of how the FDA works and representation of many parties in this area gives her a perspective that no one else has.
Peter is such an expert, he is very technical and precise and in the details.
Peter has a deep understanding of the rules and regulations; he can issue advice quickly and with a level of detail and pragmatism that is deeply appreciated.